Inventor · disambiguated record
Brian A. Zabel
Also filed as: ZABEL BRIAN · ZABEL BRIAN A
11 granted patents·9 pending applications·69 citations·filing 1999–2023
88Inventor score
Files withUNIV LELAND STANFORD JUNIOR6MILLENNIUM PHARM INC5CURIA IP HOLDINGS LLC4WASHINGTON UNIVERSITY ST LOUIS2GRAHAM KAREEM1
Top patents by PatentIndex Score
20 records- 0185US6689570B2Methods of identifying agents which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·50 claims
- 0283US7381412B2Anti-TECK antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2005·Granted Jun 3, 2008·4 cites·4 claims
- 0382US6884574B2Methods of identifying agents which inhibit GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Apr 26, 2005·12 cites·35 claims
- 0480US6329159B1Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 functionMILLENNIUM PHARM INC·Filed 1999·Granted Dec 11, 2001·30 cites·43 claims
- 0577US11384146B2BTLA-binding antibodies for modulating immune response and treating diseaseLAKEPHARMA INC·Filed 2020·Granted Jul 12, 2022·2 cites·7 claims
- 0674US9265738B2Small molecule CMKLR1 antagonists in demyelinating diseaseUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Feb 23, 2016·1 cites·9 claims
- 0771US7485301B2Methods of treating inflammatory disease using antibodies which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 3, 2009·3 cites·19 claims
- 0863US2024075155A1Compositions comprising chemerin and methods of use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 0957US8038992B2Target for regulating multiple sclerosisUNIV LELAND STANFORD JUNIOR·Filed 2009·Granted Oct 18, 2011·0 cites·2 claims
- 1056US2005202029A1Family of cystatin-related chemoattractant proteinsUNIV LELAND STANFORD JUNIOR·Filed 2004·Application pending·0 cites
- 1155US2022372114A1Sars-cov-2 spike protein antibodiesCURIA IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1255US2023340123A1Btla-binding antibodies for modulating immune response and treating diseaseCURIA IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1355US2024239875A1Sars-cov-2 spike protein antibodiesCURIA IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1454US11938193B2Compositions comprising chemerin and methods of use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2017·Granted Mar 26, 2024·0 cites·17 claims
- 1552US11730705B2Small molecule CMKLR1 antagonists in inflammatory diseaseUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Aug 22, 2023·0 cites·8 claims
- 1647US2010092974A1Methods for screening for modulators of ccrl2UNIV LELAND STANFORD JUNIOR·Filed 2009·Application pending·0 cites
- 1746US2012064092A1Novel Target for Regulating Multiple SclerosisGRAHAM KAREEM·Filed 2011·Application pending·0 cites
- 1846US2023115257A1Sars-cov-2 spike protein antibodiesCURIA IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1945US9868792B2Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptorUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jan 16, 2018·0 cites·6 claims
- 2044US2007286863A1CMKLR regulation of adipogenesis and adipocyte metabolic functionSINAL CHRISTOPHER·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian A. Zabel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →